Home » Elan Clarifies Reported News on Bapineuzumab Phase 3 Trials Duration
Elan Clarifies Reported News on Bapineuzumab Phase 3 Trials Duration
January 13, 2009
Elan Corp. clarified the recent reports that stated that the duration of the bapineuzumab Phase 3 clinical trials may be extended.
RTTNews
RTTNews
Upcoming Events
-
21Oct